2nd World Congress on Interventional Therapies for Type 2 Diabetes March 28-30, 2011 Hilton New York • New York, NY • USA Congress Director Francesco Rubino, MD Congress Program www.wcidt.org Hosted By Welcome to the 2nd World Congress on Interventional therapies for Type 2 diabetes Dear Colleagues and Friends, Several gastrointestinal (GI) operations originally designed to treat morbid obesity also cause dramatic improvement or even remission of type 2 diabetes. The mechanisms by which surgery controls hyperglycemia remain elusive. Increasing evidence suggests that weight-independent mechanisms may play a role in the surgical control of diabetes. This knowledge challenges current paradigms of disease pathogenesis and points to the gastrointestinal tract as a potential target for the development of less invasive interventional therapies and novel pharmaceuticals. Previously, the Diabetes Surgery Summit (Rome 2007) and the 1st World Congress on Interventional Therapies for Type 2 Diabetes (New York 2008), have raised attention about the role of gastrointestinal surgery for the treatment of diabetes: opportunities and limitations of this emerging field are now the matter of a growing debate. The debate continues with the 2nd World Congress on Interventional Therapies for Type 2 Diabetes. A multidisciplinary group of clinicians, scientists and policy makers will address barriers that still prevent access to surgical treatment of diabetes in eligible patients and develop an agenda of research priorities to improve patients selection and elucidate mechanisms of diabetes control. A stellar Faculty of leading international scientists will also discuss how the lessons learned from study of gastrointestinal interventions may improve understanding of diabetes and provide a lead for future treatments of curative intent. On behalf of the organizing committee and myself, I welcome you to this exciting, multidisciplinary event. Francesco Rubino, MD Congress Director 1 2nd World Congress on Interventional Therapies for Type 2 Diabetes EDUCATIONAL PARTNER American Diabetes Association ENDORSING SOCIETIES The 2nd World Congress on Interventional Therapies for Type 2 Diabetes is endorsed by the following organizations. ™ 100 SW 75th Street Suite 201 Gainesville, FL 32607 American Association of American Association of American Gastroenterological American Society for Metabolic Clinical Endocrinologists Endocrine Surgeons Association and Bariatric Surgery Asociacion De Cirugia Bariatrica Y Metabolica De Guatemala Asia Pacific, Metabolic & Asociation Latinoamericana Association for the Bariatric Surgery Society De Circurjanos Endoscpistas Study of Obesity Emirates Obesity Surgery Interest Group Belgian Endocrine Society Canadian Diabetes Diabetes UK Association European Association for Gastroenterology IFSO Sweden and Endoscopy European Association for Indian Association of Gastrointestinal the Study of Diabetes Endo-Surgeons International Atherosclerosis Endocrine Society European Association for International Federation for the Surgery Society Endoscopic Surgery of Obesity and Metabolic Disorders 2nd World Congress on Interventional Therapies for Type 2 Diabetes • March 28-30, 2011 • New York, NY, USA • www.wcidt.org 2 2nd World Congress on Interventional Therapies for Type 2 Diabetes Italian Society of Japan Society for the Study National Obesity Forum The New York Endocrinology of Obesity Academy of Sciencs Obesity & Metabolic Surgery The Obesity Society Obesity Surgery Society of The Philippine Society for Society of India Australia & New Zealand Metabolic and Bariatric Surgery Research Society for the Study of Diabetes in India Qatar Diabetes Sociedad Argentina Sociedade Brasileira de Cirurgia Association – Qatar Foundation de Diabetes Bariatrica e Metabolica Sociedade Brasileira Sociedade Brasileira de Sociedad de Cirujanos Sociedad Espanola de Diabetes (SBD) Endocronologia e Metabologia de Chile de Diabetes Società Italiana di Diabetologia Società Italiana dell'Obesità Società Italiana di Chirurgia dell’Obesità Società Italiana per la e delle malattie metaboliche Prevezione Cardiovascolare Society for Society of American Gastrointestinal The Society for Surgery Swiss Society for the Study of Morbid Endocrinology and Endoscopic Surgeons of the Alimentary Tract Obesity and Metabolic Disorders This program is supported in name only by the American Heart Association’s Councils on Basic Cardiovascular Sciences, Clinical Cardiology, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, Kidney in CV Disease, and High Blood Pressure Research. http://www.heart.org/HEARTORG/ 2nd World Congress on Interventional Therapies for Type 2 Diabetes • March 28-30, 2011 • New York, NY, USA • www.wcidt.org 3 2nd World Congress on Interventional Therapies for Type 2 Diabetes The International Diabetes Federation (IDF) Position Statement on Interventional Treatments of Type 2 Diabetes During the World Congress, the IDF will officially announce its Position Statement on Metabolic/Bariatric Surgery and GI Interventions for the Treatment of Diabetes Monday, March 28, 2011 11:10 am - 12:30 pm • Grand Ballroom, Hilton New York The IDF consensus developing meeting was held at the IDF head office in Brussels, Belgium (5-6 December, 2010). This meeting was convened by: Professor George Alberti Professor Paul Zimmet Imperial College, London and Newcastle University, UK Baker IDI Heart & Diabetes Institute, Melbourne, Australia Professor John B. Dixon Professor Francesco Rubino Baker IDI Heart & Diabetes Institute, Melbourne, Australia Weill Cornell Medical College, New York, NY, USA Other attendees at the meeting were: Professor Stephanie Amiel Professor Pierre Lefebvre King's College London, UK IDF and University of Liege, Belgium Professor Louise A. Baur Dr. Carel Le Roux University of Sydney, Australia Imperial College London, UK Professor Nam H. Cho Professor Jean-Claude Mbanya Ajou University School of Medicine, Korea International Diabetes Federation, Cameroon Dr. Bruno Geloneze Professor Gertrude Mingrone University of Campinas (UNICAMP), Brazil Catholic University of Rome, Italy Professor Jan Willem Greve Professor Philip R. Schauer Atrium Medical Center, Netherlands Cleveland Clinic Lerner College of Medicine, USA Professor Linong Ji Professor Luc Van Gaal Peking University People's Hospital, China Antwerp University Hospital, Belgium Dr. Muffazal Lakdawala Dr. David Whiting Saifee Hospital, India International Diabetes Federation, Belgium Professor Wei-Jei Lee Professor Bruce M. Wolfe Ming-Sheng General Hospital, National Taiwan Oregon Health and Science University (OHSU), USA University, Taiwan All panel members made a substantial contribution to the meeting and subsequent formulation of the position statement. The consensus meeting was supported with an unrestricted educational grant by: Allergan Inc, Irvine, CA, USA Ethicon, Ethicon Endo-Surgery, Inc, Cincinnati, Ohio, USA MetaCure Inc, Mount Laurel, NJ, USA These companies played no role in the discussion or preparation of the IDF position statement. 4 2nd World Congress on Interventional Therapies for Type 2 Diabetes • March 28-30, 2011 • New York, NY, USA • www.wcidt.org 2nd World Congress on Interventional Therapies for Type 2 Diabetes Contents Welcom e................................... 1 Endorsing Societie s............................ 2-3 International Diabetes Federation Statement ............... 4 General Informatio n............................ 6-7 Congress Advisory Committe e....................... 9 Congress Program Committe e.................... 11-13 Distinguished Facult y .......................... 14-21 Guest Expert s................................ 22 Program-At-A-Glanc e ......................... 23-24 PROGRAM Monday, March 28 .......................... 26-27 Tuesday, March 29 .......................... 28-32 Breakout Sessions/Workshops ................... 30-32 Wednesday, March 30 ........................ 33-34 Faculty Index ................................. 35 Exhibitor Director y ............................ 37-38 Exhibit Floor Pla n.............................. 38 Poster Sessions .............................. 39 Diabetes: A Global Epidemi c ....................... 41 Gastrointestinal Procedure s...................... 43-47 Disclosure s ............................... 48-49 Congress Sponsors ............................. 50 2nd World Congress on Interventional Therapies for Type 2 Diabetes GENERAL INFORMATION The World Congress will take place March 28-30, 2011 at the Hilton New York, 1335 Avenue of the Americas, New York, NY 10013 Telephone: (+1) 212-586-7000 • Guest Fax: (+1) 212-315-1374 EDUCATIONAL DISCLAIMER SPEAKER READY ROOM The primary purpose of this congress is education. Information All Congress speakers are required to check in at the Speaker presented, as well as publications, technologies, and/or services Ready Room no later than two hours in advance of your discussed, are intended to inform you about the knowledge, presentation. The Speaker Ready Room is located in the techniques, and experiences of the faculty who are willing to Gibson Suite on the hotel’s second floor. share such information with colleagues. A diversity of professional opinions exists on the topics of the Congress, and Speaker Ready Room Hours: the views of the conference’s faculty are solely for educational Sunday, March 27, 2011 2:00 pm - 6:00 pm purposes. Faculty’s views neither represent those of the 2nd Monday, March 28, 2011 7:00 am - 6:00 pm World Congress on Interventional